ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
122.098,09
-0,50%
S&P 500
5.277,51
0,80%
US Dollar vs BRL
5,2463
0,00%
Bitcoin
68.051,34
0,48%
Brent Oil
81,295
0,00%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Immunocore Holdings PLC (IMCR)

  7. Immunocore Holdings PLC (IMCR) Notícias

IMCR

Immunocore (IMCR)

Immunocore Holdings PLC
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:IMCR
DataHoraFonteTítuloCódigoCompanhia
01/06/202409:00GlobeNewswire Inc.Immunocore presents KIMMTRAK clinical data demonstrating that patients with stable disease and confirmed tumor reduction have similar clinical outcomes to patients with partial responseNASDAQ:IMCRImmunocore Holdings PLC
31/05/202417:21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMCRImmunocore Holdings PLC
31/05/202417:05GlobeNewswire Inc.Immunocore reports updated Phase 1 data of brenetafusp (IMC-F106C), an ImmTAC bispecific targeting PRAME, in immune checkpoint pre-treated cutaneous melanoma patients at ASCO 2024NASDAQ:IMCRImmunocore Holdings PLC
30/05/202417:00GlobeNewswire Inc.Immunocore to present at the Jefferies Global Healthcare ConferenceNASDAQ:IMCRImmunocore Holdings PLC
29/05/202408:00GlobeNewswire Inc.Immunocore converts Phase 2/3 TEBE-AM clinical trial into registrational Phase 3 trial evaluating KIMMTRAK for previously treated advanced cutaneous melanomaNASDAQ:IMCRImmunocore Holdings PLC
28/05/202417:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMCRImmunocore Holdings PLC
08/05/202408:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IMCRImmunocore Holdings PLC
08/05/202408:00GlobeNewswire Inc.Immunocore reports first quarter financial results and provides a business updateNASDAQ:IMCRImmunocore Holdings PLC
24/04/202411:00GlobeNewswire Inc.Immunocore announces upcoming presentation and posters at ASCO 2024NASDAQ:IMCRImmunocore Holdings PLC
04/04/202417:00GlobeNewswire Inc.Immunocore to present at upcoming investor conferencesNASDAQ:IMCRImmunocore Holdings PLC
05/03/202418:30GlobeNewswire Inc.Immunocore presented two posters at CROI 2024NASDAQ:IMCRImmunocore Holdings PLC
28/02/202409:34GlobeNewswire Inc.Immunocore reports fourth quarter and full year 2023 financial results and provides a business updateNASDAQ:IMCRImmunocore Holdings PLC
28/02/202409:33Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:IMCRImmunocore Holdings PLC
26/02/202420:46Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IMCRImmunocore Holdings PLC
22/02/202409:00GlobeNewswire Inc.Immunocore announces clinical trial collaboration and supply agreement with Bristol Myers Squibb to evaluate IMC-F106C (PRAME HLA-A02) in combination with nivolumab in its registrational Phase 3 first-line advanced cutaneous melanoma trialNASDAQ:IMCRImmunocore Holdings PLC
21/02/202409:00GlobeNewswire Inc.Immunocore to report fourth quarter and full year 2023 financial results and host call on February 28, 2024NASDAQ:IMCRImmunocore Holdings PLC
31/01/202401:30GlobeNewswire Inc.Immunocore Prices Upsized Convertible Senior Notes OfferingNASDAQ:IMCRImmunocore Holdings PLC
29/01/202418:05GlobeNewswire Inc.Immunocore Announces Proposed Convertible Senior Notes OfferingNASDAQ:IMCRImmunocore Holdings PLC
05/01/202409:00GlobeNewswire Inc.Immunocore announces strategic priorities and pipeline expansion ahead of 42nd Annual J.P. Morgan Healthcare Conference presentationNASDAQ:IMCRImmunocore Holdings PLC
03/01/202409:00GlobeNewswire Inc.Immunocore to present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:IMCRImmunocore Holdings PLC
02/01/202418:57Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:IMCRImmunocore Holdings PLC
30/11/202306:00GlobeNewswire Inc.Levicept Appoints Eliot Forster as CEONASDAQ:IMCRImmunocore Holdings PLC
07/11/202309:09Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMCRImmunocore Holdings PLC
07/11/202309:00GlobeNewswire Inc.Immunocore Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:IMCRImmunocore Holdings PLC
01/11/202317:01GlobeNewswire Inc.Immunocore announces upcoming poster presentations at SITC Annual Meeting 2023 and SMR Congress 2023NASDAQ:IMCRImmunocore Holdings PLC
21/10/202309:45GlobeNewswire Inc.Immunocore presents three-year overall survival data from the KIMMTRAK Phase 3 trialNASDAQ:IMCRImmunocore Holdings PLC
06/10/202308:01GlobeNewswire Inc.Immunocore announces upcoming presentation and posters at ESMO 2023NASDAQ:IMCRImmunocore Holdings PLC
10/08/202308:00GlobeNewswire Inc.Immunocore Reports Second Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:IMCRImmunocore Holdings PLC
03/08/202309:00GlobeNewswire Inc.Immunocore to report second quarter 2023 financial results and host call on August 10, 2023NASDAQ:IMCRImmunocore Holdings PLC
15/06/202318:18Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:IMCRImmunocore Holdings PLC
 Apresentando as notícias mais relevantes sobre:NASDAQ:IMCR

Seu Histórico Recente

USOTC
RWWNS
RSE Collection (GM)
LSE
79QO
Roy.bk.can. 26
NASDAQ
SWATU
A4S Security Unit
BIT
GEO
Geox
LSE
76RT
Cred Ag Co. 25
BIT
P17XJ0
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados